Chen Jianbin, Xiang Nan, Xu Lili, Zeng Shuiqing
Department of Ophthalmology, Tongji Hospital, Tongji Medial College, Huazhong University of Science and Technology, Wuhan 430030, China.
J Huazhong Univ Sci Technolog Med Sci. 2006;26(4):392-5. doi: 10.1007/s11596-006-0402-1.
The proliferating cell nuclear antigen (PCNA) gene expression was blocked and retinal pigment epithelium (RPE) proliferation was inhibited by using antisense oligonucleotides (AS-ODN) mediated by liposome, to find a new genetic therapy of proliferative vitreoretinopathy (PVR). RPE cells cultured in vitro were transfected with synthetic fluorescence labled AS-ODN mediated by liposome-Lipofectamine, and the intracellular distribution and persistence time of AS-ODN were dynamically observed. AS-ODN (0.07, 0.28 and 1.12 micro mol/L and sense oligonucleotides (S-ODN with the same concentrations as AS-ODN) mediated by liposome were delivered to the RPE cells cultured in vitro, and CPM values were measured by 3H-TdR incorporation assay and analyzed statistically by variance by comparison with blank control group. Expression of PCNA mRNA in RPE cells was detected by in situ hybridization after the treatment of different concentrations of PCNA AS-ODN and S-ODN, and the average optic density (AOD) was measured by image analysis system and was subjected to q-test and correlation analysis with CPM. Our results showed that AS-ODN mediated by liposome could quickly aggregate in cellular plasma and nuclei in 30 min and 6 h, and stayed for as long as 6 days. AS-ODN (0.28 and 1.12 micro mol/L) markedly suppressed proliferation of RPE cells in a dose-dependent manner with the difference being statistically significant (P < 0.05 and P < 0.01, repectively) as compared with blank control group. AOD was well correlated with CPM (r = 0.975). It is concluded that liposome could increase transfection efficiency of AS-ODN in RPE cells, and AS-ODN could sequence-specifically suppress PCNA mRNA expression and proliferation of human RPE cells.
利用脂质体介导的反义寡核苷酸(AS-ODN)阻断增殖细胞核抗原(PCNA)基因表达,抑制视网膜色素上皮(RPE)细胞增殖,以寻找增殖性玻璃体视网膜病变(PVR)的新基因治疗方法。用脂质体Lipofectamine介导的合成荧光标记AS-ODN转染体外培养的RPE细胞,动态观察AS-ODN在细胞内的分布及存留时间。将脂质体介导的AS-ODN(0.07、0.28和1.12 μmol/L)及相同浓度的正义寡核苷酸(S-ODN)导入体外培养的RPE细胞,采用3H-TdR掺入法检测CPM值,并与空白对照组比较进行方差统计分析。用不同浓度的PCNA AS-ODN和S-ODN处理后,通过原位杂交检测RPE细胞中PCNA mRNA的表达,用图像分析系统测量平均光密度(AOD),并与CPM进行q检验和相关性分析。结果显示,脂质体介导的AS-ODN在30分钟和6小时可快速聚集于细胞质和细胞核内,并可存留长达6天。AS-ODN(0.28和1.12 μmol/L)以剂量依赖方式显著抑制RPE细胞增殖,与空白对照组相比差异有统计学意义(分别为P<0.05和P<0.01)。AOD与CPM相关性良好(r=0.975)。结论:脂质体可提高AS-ODN在RPE细胞中的转染效率,AS-ODN可序列特异性抑制人RPE细胞PCNA mRNA表达及细胞增殖。